ORIC Pharmaceuticals
ORIC Pharmaceuticals
oricpharma.com

Locations

United States · San Francisco, CA, USA · South San Francisco, CA, USA · San Diego, CA, USA

industry

Biotechnology

Size

51 - 200 employees

Stage

IPO

founded in

2014

Oric pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by overcoming resistance in cancer. Oric’s clinical stage product candidates include (1) oric-944, an allosteric inhibitor of the polycomb repressive complex 2 (prc2) via the eed subunit, being developed for prostate cancer, and (2) enozertinib (oric-114), a brain penetrant inhibitor designed to selectively target egfr exon 20, her2 exon 20 and egfr atypical mutations in nsclc. Oric has offices in south san francisco and san diego, california. For more information, please go to www.oricpharma.com, and follow us on x or linkedin.

Something looks off?
Open jobs at ORIC Pharmaceuticals

On-site & Remote